VA
ELV icon

Verdad Advisers’s Elevance Health ELV Stock Holding History

Verdad Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Buy
+709
New +$233K 0.23% 130
2024
Q3 		$1.63M Buy
3,134
+119
+4% +$63.6K 2.18% 8
2024
Q2 		$1.63M Buy
3,015
+865
+40% +$457K 1.89% 8
2024
Q1 		$1.11M Buy
+2,150
New +$1.07M 1.21% 19

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Verdad Advisers's ELV Position: Q1 2026 in Review

Verdad Advisers opened a new position in Elevance Health (ELV) in Q1 2026: 709 shares worth $208K. The stake represents 0.23% of the portfolio and ranks #130 among its holdings. This is a return to the name: Verdad Advisers previously reported a position in ELV as recently as Q3 2024.

Verdad Advisers first reported a position in ELV in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.63M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Verdad Advisers held 709 shares of Elevance Health worth $208K as of Q1 2026.
  • Elevance Health was a new Verdad Advisers position in Q1 2026.
  • Elevance Health made up 0.23% of Verdad Advisers's portfolio in Q1 2026, its #130 holding.
  • Verdad Advisers first reported a position in Elevance Health in Q1 2024 and has held it in 4 quarters since.
  • Verdad Advisers's Elevance Health position peaked at $1.63M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.